Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
ENDRA Life Sciences Inc. (NDRA) had Return on Tangible Equity of -83.22% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.23M |
|
-- |
|
-- |
|
$1.30M |
|
$-1.30M |
|
$0.08M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.30M |
|
$-1.27M |
|
0.72M |
|
0.72M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$1.85M |
|
$0.06M |
|
$0.95M |
|
$2.81M |
|
$0.58M |
|
-- |
|
$0.76M |
|
$1.33M |
|
$1.47M |
|
$1.47M |
|
$1.47M |
|
0.75M |
|
| Cash Flow Statement Financials | |
$-2.41M |
|
$-0.02M |
|
$1.00M |
|
$3.23M |
|
$1.81M |
|
$-1.42M |
|
$0.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-83.22% |
|
|
Return on Tangible Equity |
-83.22% |
-43.66% |
|
-83.22% |
|
$1.96 |
|
$-3.38 |
|
$-3.36 |
|